Keywords: بیوپسی مایع; Liquid biopsy; Fine needle aspiration; Cytology; Supernatant; Lung cancer; EBUS-TBNA;
مقالات ISI بیوپسی مایع (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: بیوپسی مایع; Biomarker; Cell-free DNA; Droplet digital polymerase chain reaction; Liquid biopsy; Neoadjuvant chemotherapy; Minimally invasive monitoring; Personalised analysis; Plasma; Reservoir urine; Treatment response;
Keywords: بیوپسی مایع; Prostate cancer; Androgen receptor; cfDNA; ctDNA; CTC; Liquid biopsy;
Keywords: بیوپسی مایع; Colon cancer; Gene mutation; Genomic evolution; Liquid biopsy; Next-generation sequencing;
Keywords: بیوپسی مایع; Bladder cancer; Circulating tumor cells; CTCs; Cell-free DNA; cfDNA; miRNA; RNA; Biomarker; Diagonostic; Liquid biopsy;
Keywords: بیوپسی مایع; Lung cancer; Circulating tumor cells; Liquid biopsy; Prognosis;
Keywords: بیوپسی مایع; Protein leakage markers; Liquid biopsy; Early detection of disease; Tissue-specific proteins; Exocrine secretion; Recombinant protein binders; Dual-recognition assays; Sandwich immune assay; Proximity ligation assay; Proximity extension assay; Dried blood
Keywords: بیوپسی مایع; Circulating tumor cells (CTCs); Cell enrichment; Point of care; Liquid biopsy; Personalized therapies;
Keywords: بیوپسی مایع; Circulating tumor cells; Colorectal cancer; Liquid biopsy; RAS; Tumor heterogeneity;
Keywords: بیوپسی مایع; Colorectal cancer; Liquid biopsy; KRAS; NRAS; BRAF;
Keywords: بیوپسی مایع; Circulating tumor cells; Biomarker; Melanoma; Cancer; Liquid biopsy;
Keywords: بیوپسی مایع; Circulating tumor cells; Liquid biopsy; Prognostic biomarker; Predictive biomarker; Circulating tumor DNA; Clinical utility; Clinical application;
Keywords: بیوپسی مایع; Cancer; Liquid biopsy; Circulating tumor cells; Precision therapy; Prognostic biomarker; Predictive biomarker; Early cancer detection; Tumor heterogeneity;
Keywords: بیوپسی مایع; Colorectal carcinoma; Liquid biopsy; Biomarker; Prognostic; Predictive;
Keywords: بیوپسی مایع; Nanomedicine; Nanodiagnostics; Liquid biopsy; Biophotonics; Pancreatic cancer detection; Pancreatic ductal adenocarcinoma; Sub-femtomolar limit of detection; AJCC; American Joint Commission on Cancer; MMP; matrix metalloproteinase; CTS; cathepsin; UpA; ur
Keywords: بیوپسی مایع; PC; prostate cancer; mPC; metastatic prostate cancer; ADT; androgen deprivation therapy; CRPC; castration resistant prostate cancer; mCRPC; metastatic CRPC; SNP; single nucleotide polymorphism; CNV; copy number variation; AR; androgen receptor; CTC; circu
Keywords: بیوپسی مایع; Circulating tumor cells; Non small cell lung cancer; Epidermal growth factor receptor; Anaplastic lymphoma kinase fusion gene; Liquid biopsy;
Keywords: بیوپسی مایع; Circulating tumor cells; Liquid biopsy; Pancreatic cancer; The CellSearch system; Chemotherapy and chemoradiotherapy;
Keywords: بیوپسی مایع; Liquid biopsy; Cell-free DNA; Platelets; Tumor-related RNA; Non-small cell lung cancer;
Keywords: بیوپسی مایع; Urologic cancers; Cell-free nucleic acid; Liquid biopsy; Early detection; Recurrence monitoring; Precision medicine;
Keywords: بیوپسی مایع; BRCA2; Circulating tumor DNA; Cell-free DNA; Liquid biopsy; Enzalutamide; Abiraterone; Castration-resistant prostate cancer; DNA repair;
Keywords: بیوپسی مایع; Rebiopsie; Cancer bronchique non à petites cellules; Biopsie liquide; Rebiopsy; Non-small cell lung cancer; Liquid biopsy;
Keywords: بیوپسی مایع; Diagnostics; Exosomes; Extracellular vesicles; High-throughput quantitative lipidomics; Lipids; Liquid biopsy; Non-invasive biomarkers; Prostate cancer; Urine;
Keywords: بیوپسی مایع; ABC; advanced breast cancer; CGH; comparative genomic hybridization; CNA; copy number alterations; CTC; circulating tumor cells; ctDNA; cell-free tumor DNA; DEP; dielectrophoretic; DFS; disease-free survival; dPCR; digital PCR; EBC; early breast cancer; E
Keywords: بیوپسی مایع; cfDNA; cell-free DNA; CNI; copy number instability; ctDNA; circulating tumor cell-free DNA; ddPCR; droplet digital PCR; GcfDNA; graft-derived cell-free DNA; LC-MS/MS; liquid chromatography tandem mass spectrometry; MIC; minimum inhibitory concentration; N
Keywords: بیوپسی مایع; NSCLC; Plasma genotyping; Liquid biopsy; Targeted therapy; EGFR; Acquired resistance;
Keywords: بیوپسی مایع; Liquid biopsy; Comprehensive sequencing; Concordance study; Hybrid-capture;
Keywords: بیوپسی مایع; Biopsies; Imaging; Liquid biopsy; Serum proteins; Tumor-associated autoantibodies;
Keywords: بیوپسی مایع; Prostate cancer; Circulating tumor cell; Biomarker; Liquid biopsy; Molecular oncology;
Keywords: بیوپسی مایع; Cancer; Circulating cell-free DNA; Liquid biopsy; Conducting polymer; Lung cancer; Mutation detection
Keywords: بیوپسی مایع; CTCs; DTCs; Cell lines; Solid tumors; Biomarkers; Liquid biopsy;
Keywords: بیوپسی مایع; Carcinome de primitif inconnu; Immunohistochimie; Biopsie liquide; Chimiothérapie; Séquençage du génome; Médecine de précision; Cancer of unknown primary; Immunohistochemistry; Liquid biopsy; Chemotherapy; Genome sequencing; Precision medicine;
Keywords: بیوپسی مایع; Cell-free DNA; CTC; Liquid biopsy; miRNA; NSCLC;
Keywords: بیوپسی مایع; Circulating tumor cells; Circulating tumor DNA; Liquid biopsy; Pancreatic cancer;
Keywords: بیوپسی مایع; Melanoma; Liquid biopsy; Circulating tumor cells; Cell-free circulating tumor DNA; Cell-free DNA; Cell-free microRNA; Ab; antibody; AIM1; absent in melanoma-1; AJCC; American Joint Committee on Cancer; BRAF; B-Raf proto-oncogene, serine/threonine kinase;
Keywords: بیوپسی مایع; Liquid biopsy; Targeted therapy; Circulating tumor cell (CTC); Cell-free nucleic acid (cfNA); Exosomes; Extracellular vesicle (EV);
Keywords: بیوپسی مایع; CRC; colorectal cancer; CTCs; circulating tumor cells; cfDNA; cell-free DNA; HMs; histon modifications; LOH; loss of heterozygosity; miRNAs; microRNAs; MSI; microsatellite instability; Colorectal cancer; Blood-based biomarkers; Liquid biopsy; Circulating
Keywords: بیوپسی مایع; Liquid biopsy; Biomarker; Blood; DNA; Circulating tumour cells; RNA
Keywords: بیوپسی مایع; Extracellular vesicles; Exosomes; Oncosomes; miRNA biomarkers; Liquid biopsy; Nanobiomedicine;
Keywords: بیوپسی مایع; DNA methylation; Histone modification; Biomarker; Liquid biopsy; Epigenetic therapy;
Keywords: بیوپسی مایع; cellules tumorales circulantes; tumeurs solides; pronostic; biopsie liquide; circulating tumor cells; solid tumors; prognosis; liquid biopsy;
Keywords: بیوپسی مایع; Liquid biopsy; Microfluidic assay; Non-blood body fluids; Circulating tumor cells (CTCs); Mobile tumor cells (MTCs); Single cell sequencing;
Keywords: بیوپسی مایع; HNSCC; Liquid biopsy; Heterogeneity; ctDNA; CTC
Keywords: بیوپسی مایع; Circulating tumor DNA; Liquid biopsy; Intra-tumor heterogeneity; Disease monitoring; Molecular resistance; Early detectionctDNA, circulating tumor DNA; MPS, massive parallel sequencing; MRD, minimal residual disease; NGS, Next Generation Sequencing; PCR,
Keywords: بیوپسی مایع; Trophoblastic tumor; Hydatidiform mole; Cell free DNA; Circulating tumor DNA; Molecular genotyping; Liquid biopsy
Frequencies and expression levels of programmed death ligand 1 (PD-L1) in circulating tumor RNA (ctRNA) in various cancer types
Keywords: بیوپسی مایع; PD-L1; Circulating tumor DNA; Liquid biopsy; Cancer;
Predicting therapy response and resistance in metastatic prostate cancer with circulating tumor DNA
Keywords: بیوپسی مایع; cfDNA; ctDNA; Liquid biopsy; Castration-resistant; CRPC; Cell-free DNA;
Circulating tumor DNA testing in advanced non-small cell lung cancer
Keywords: بیوپسی مایع; Circulating tumor DNA; Liquid biopsy; Biomarker; Non-small cell lung cancer; Epidermal growth factor receptor; Drug resistance;
ctDNA and CTCs in Liquid Biopsy - Current Status and Where We Need to Progress
Keywords: بیوپسی مایع; Liquid biopsy; Circulating tumor DNA; Circulating tumor cells; Pre-analytical handling; Technology overview;
ESR1 methylation in primary tumors and paired circulating tumor DNA of patients with high-grade serous ovarian cancer
Keywords: بیوپسی مایع; Estrogen receptor; ESR1; Liquid biopsy; High-grade serous ovarian cancer; Circulating tumor DNA; Methylation specific PCR;